Remove 2007 Remove Diabetes Remove Labelling
article thumbnail

FDA OKs first biosimilar of Roche’s blockbuster AMD drug Lucentis

pharmaphorum

The approval comes a few weeks after the biosimilar was cleared for marketing in the EU with a broader label, as it also includes diabetic macular oedema (DMO), another of Lucentis’ approved indications. Sales reached a peak in 2019, when Roche booked $1.8 billion in sales from the drug while Novartis made $2.1 billion and $1.9

article thumbnail

Pressure rises on Lucentis, as Coherus biosimilar gets FDA nod

pharmaphorum

Byooviz launched on 1 July at a 40% discount to Lucentis, with a label that covers use of the biosimilar for wet age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), and myopic choroidal neovascularisation. Roche has US marketing rights to the drug, and booked $1.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Japan’s M&A Boom

Pharmaceutical Technology

“The business integration from 2005 to 2007 of the two separate companies to form the joint Daiichi Sankyo created one of Japan’s biggest pharmaceutical companies.” Like in many other sectors, China and India are the ones labelled as those which will lead the expansion. % increase over the previous year.

article thumbnail

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Quality Matters

By enabling a multi-manufacturer environment, USP standards have helped increase the availability of medicines to treat cardiovascular disease, cancer, diabetes, mental health and many other conditions. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

Its flagship product Humira achieved a $2B global revenue Additionally, Abbott acquired Kos Pharmaceuticals and Guidant's vascular business and launched a new division, Abbott Nutrition International 2007 was a great year for Johnson & Johnson, its consumer health business showed a drastic growth of 48.3% over the previous year.

article thumbnail

Selenium: The Nutrient That Can Reduce Thyroid Antibodies by 40%

The Thyroid Pharmacist

Selenium intake may also cause side effects in those with diabetes. One study found that people who took 200 micrograms a day of selenium, were 50 percent more likely to develop type 2 diabetes. (64) Exp Clin Endocrinol Diabetes. Exp Clin Endocrinol Diabetes. 2007 Jul;17(7):609-12. 2007 Jul;17(7):609-12.

Dosage 59
article thumbnail

Air Quality and Hashimoto’s – Is the Air You’re Breathing Making You Sick?

The Thyroid Pharmacist

Perhaps more concerning, of the 133 different VOCs found across all tested products, only one, ethanol, was actually listed on any label! (13, For sunscreens and other over-the-counter drugs, fragrances must be identified on the label. But formaldehyde has been labeled as a known human carcinogen by the U.S. Accessed April 2022.